Search research articles
Contact Us
Filters
Showing results (41-50 of 346) with videos related to
Page
of 35
Sort By:
The American Journal of Medicine
|
January 7, 2000
Acute porphyria: the cost of suspicion
S E Mattern, A Tefferi
European Journal of Haematology
|
December 12, 2001
Correction to response to Pearson (Eur J Hematol 67(1): 56-69) on normal ranges for PCV and hemoglobin
V F Fairbanks, A Tefferi
Blood
|
February 24, 2001
Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia
A Tefferi, M A Elliot
Mayo Clinic Proceedings
|
February 1, 1994
The biochemical basis of cobalamin deficiency
A Tefferi, R K Pruthi
British Journal of Haematology
|
April 1, 1994
Recombinant human erythropoietin therapy in patients with myelofibrosis with myeloid metaplasia
A Tefferi, M N Silverstein
American Journal of Hematology
|
July 1, 1996
Natural leukocyte interferon-alpha therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-alpha
A Tefferi, D C Grendahl
Seminars in Hematology
|
February 4, 1999
Treatment of essential thrombocythemia with anagrelide
M N Silverstein, A Tefferi
Blood Cancer Journal
|
February 6, 2016
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
M M Patnaik, A Tefferi
Blood Reviews
|
October 20, 1999
Splenic irradiation in myelofibrosis with myeloid metaplasia: a review
M A Elliott, A Tefferi
Leukemia & Lymphoma
|
September 1, 1996
Current perspective in agnogenic myeloid metaplasia
A Tefferi, M N Silverstein
Page
of 35
Search research articles
Search
Showing results (41-50 of 346) with videos related to
Sort By:
Page
of 35
The American Journal of Medicine
|
January 7, 2000
Acute porphyria: the cost of suspicion
S E Mattern, A Tefferi
European Journal of Haematology
|
December 12, 2001
Correction to response to Pearson (Eur J Hematol 67(1): 56-69) on normal ranges for PCV and hemoglobin
V F Fairbanks, A Tefferi
Blood
|
February 24, 2001
Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia
A Tefferi, M A Elliot
Mayo Clinic Proceedings
|
February 1, 1994
The biochemical basis of cobalamin deficiency
A Tefferi, R K Pruthi
British Journal of Haematology
|
April 1, 1994
Recombinant human erythropoietin therapy in patients with myelofibrosis with myeloid metaplasia
A Tefferi, M N Silverstein
American Journal of Hematology
|
July 1, 1996
Natural leukocyte interferon-alpha therapy in patients with chronic granulocytic leukemia who have antibody-mediated resistance to treatment with recombinant interferon-alpha
A Tefferi, D C Grendahl
Seminars in Hematology
|
February 4, 1999
Treatment of essential thrombocythemia with anagrelide
M N Silverstein, A Tefferi
Blood Cancer Journal
|
February 6, 2016
Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
M M Patnaik, A Tefferi
Blood Reviews
|
October 20, 1999
Splenic irradiation in myelofibrosis with myeloid metaplasia: a review
M A Elliott, A Tefferi
Leukemia & Lymphoma
|
September 1, 1996
Current perspective in agnogenic myeloid metaplasia
A Tefferi, M N Silverstein
Page
of 35